Introduction
Genetic deficiency of lysosomal enzyme, N-acetylgalactosamine-6-sulfate sulfatase (GALNS, EC 3.1.6.4), due to mutations in the GALNS gene [OMIM: 612222] leads to intralysosomal accumulation of glycosaminoglycans (GAGs): chondroitin-6-sulfate (C6S) and keratin sulfate (KS), which ultimately cause mucopolysaccharidosis IV A [Morquio A disease (MIM: 253000)] Yasuda et al., 2013) . MPS IV A is a lysosomal storage disease characterized by systemic skeletal deformities including disproportionate short stature with a short neck, pigeon chest, lumbar kyphosis, genu valgum, broad mouth and prominent maxilla in association with joint laxity, corneal clouding, valvular heart defects, and pulmonary dysfunction (Montaño et al., 2007a; Tomatsu et al., 2011; Hendriksz et al., 2013) .
Morquio A syndrome's causative gene GALNS contains 14 exons spanning 35 kb on chromosome 16q24.3 and is transcribed into 1566 base pairs cDNA that encodes 522 amino acids protein, a 60 kDa glycopeptide (Masue et al., 1991; Masuno et al., 1993) . Based on X-ray diffraction analysis, Rivera-Colón et al. (2012) demonstrated that GALNS is a homodimeric glycoprotein containing a N-terminal domain (amino acids 28-379) enclosing the active site, a second domain (amino acids 380-481), and a C-terminal disc (amino acids 482-510), which twists back toward domain 1 and delineates a portion of the active site. Comprehensive analysis of the disease-causing mutations reported in GALNS revealed that only 5% of mutations occur in the active-site residues, 65% in the buried residues of the core protein, and 27% in surface residues (RiveraColón et al., 2012) .
To date, more than 200 mutations have been reported in the GALNS gene, which include 75% point mutations (missense/nonsense), small deletions (10%), splice site mutations (8%), small insertions (1.7%), small indel (1%), gross deletions (1.7%), gross insertions/duplications (1%), and complex rearrangements (1%) (Morrone et al., 2014a (Morrone et al., , 2014b Stenson et al., 2014) . In general, this mutational heterogeneity leads to difficulties in the interpretation of patient genotypes as many patients may carry novel or poorly characterized mutations. As a general rule, the GALNS mutations have been categorized under four groups: (i) those that demolish or alter the packaging of hydrophobic core, (ii) those that eliminate the salt bridge to disrupt the entire conformation, (iii) those changing the active site geometry, or (iv) those that alter the surface of the protein to change lysosomal targeting, hydrogen bonds, or N-glycosylation sites (Sukegawa et al., 2000; Montaño et al., 2007b) . Some mutations, like nonsense mutations, large deletions, and frameshifts, have solid impact on GALNS protein activity but interpretation of missense mutations is quite challenging (Tomatsu et al., 2005; Hendriksz et al., 2013) .
The three-dimensional (3D) structure of a protein provides the framework for its dynamics and functions. In silico modeling assists in structural and functional elucidation of proteins to determine the effect of mutations on the protein structure and thus its link with disease because the function of a protein is critically dependent on a well-defined conformation (Dunker et al., 2002) . For that reason, several bioinformatics tools are employed for structural and functional analysis of missense mutations in GALNS to determine their effect on structural modifications, alterations in ligand binding affinity, and the manifestations of a positive correlation between mutations and severe phenotype (Sudhakar and Mahalingam, 2011) .
In the study presented here, eight Pakistani consanguineous families with Morquio A syndrome were evaluated at molecular level. Linkage in seven families (A, B, C, D, E, F, G) was established to GALNS on chromosome 16q24.3. Subsequent Sanger sequencing of the GALNS gene plus targeted next generation sequencing in family H revealed four novel and two previously reported mutations in the eight families. Additionally, in silico analysis was carried out to predict the mechanistic consequences of missense mutations. It was countersigned by in silico analysis that these mutations have great impact on the structure and function of the GALNS protein.
Materials and methods

Ethical approval and study subjects
Ethical approval to conduct this study was obtained from the Institutional Review Board (IRB) of Quaid-i-Azam University, Islamabad Pakistan. Mucopolysaccharidosis type IVA/Morquio A syndrome was characterized both clinically and genetically in eight consanguineous families (A, B, C, D, E, F, G, H) of Pakistani origin (Figure 1 ). Four families (A, B, C, F) were from Khyber Pakhtunkhwa (KPK), two (D, H) from Punjab, one (E) from Baluchistan, and family G was from Bajur Agency, FATA, Pakistan.
Blood samples were collected from 56 members including four affected (IV-4, IV-5, IV-6, IV-7) and seven unaffected individuals (III-1, III-2, III-3, III-4, IV-2, IV-3, IV-8) in family A, three affected (IV-4, IV-5, IV-6) and four unaffected individuals (III-1, III-2, IV-2, IV-3) in family B, two affected (IV-2, IV-3) and four unaffected individuals (III-1, III-2, IV-1, IV-4) in family C, one affected (V-1) and six unaffected individuals (IV-3, IV-4, IV-5, IV-6, V-2, V-4) in family D, two affected (IV-1, IV-2) and three unaffected individuals (III-1, III-3, IV-3, IV-4) in family E, two affected (IV-2, IV-3) and four unaffected individuals (III-1, III-2, IV-1, IV-4) in family F, two affected (IV-3, IV-4) and four unaffected individuals (III-2, III-3, IV-1, IV-2) in family G, and two affected (IV-2, IV-3) and six unaffected individuals (IV-5, IV-6, V-2, V-4, V-6, V-7) in family H.
Extraction of genomic DNA and genotyping
Genomic DNA was extracted from the blood samples using a Sigma GenElute Blood Genomic DNA kit (Sigma Aldrich, St Louis, MO, USA). Based on clinical phenotypes, DNA samples from affected and unaffected individuals of the eight families (A, B, C, D, E, F, G, H) were tested for linkage using microsatellite markers flanking GALNS on chromosome 16q24.3. PCR was performed to check linkage in these families as described previously (Irfanullah et al., 2015) . Linkage in seven families was established to the GALNS gene using twelve microsatellite markers (D16S498, D16S486, D16S3123, D16S3074, D16S3077, D16S3063, D16S3123, D16S689, D16S2621, D16S3023, D16S3026, D16S3121).
Targeted next generation sequencing
Family H was not linked to chromosome 16q24.3. Therefore, it was submitted for next generation sequencing at the Institute of Human Genetics, Jena University Hospital, Jena, Germany. A DNA sample of one affected member (V-5) was subjected to targeted resequencing using an Illumina kit: Trusight one sequencing panel on a NextSeq 500 platform that is designed for enrichment and final analysis of a panel of coding regions of almost 5000 genes (www.illumina.com/products/trusight-onesequencing-panel.ilmn). The kit contained all the reagents required for the amplification, amplicon enrichment, indexing of the samples, and the use of NextSeq 500. First of all, an indexed, pooled library was prepared from genomic DNA using integrated barcodes according to the manufacturer's protocol. Then the targeted regions were hybridized with biotinylated probes followed by enrichment with streptavidin beads to prepare sequencing ready fragments. Finally, the libraries were loaded to a flow cell for sequencing using an Illumina NextSeq 500 instrument. Fastq files were aligned to the hg19 human reference sequence using the Burrows-Wheeler Aligner (BWA) (Li et al., 2009) . Variant detection and calling were performed using the a Genome Analysis Toolkit (GATK) (McKenna et al., 2010; DePristo et al., 2011) to produce variant calling files (VCF). NextGene software (SoftGenetics LLC) was used for data processing, alignment, variant calling, and annotation. Before variant analysis and interpretation was started, intergenic and frequent (with a frequency above 0.001 in single nucleotide polymorphism database, dbSNP132 (ftp://ftp.ncbi.nlm. nih.gov/snp/00readme.txt) or the 1000 Genomes Project Database (www.1000genomes.org)) variants were excluded. As a final point, the variants with average coverage >30x and read quality >Q20 were filtered for missense, nonsense, frameshift, and splice site mutations.
Sanger sequencing
All 14 exons of GALNS (MIM 253000) with adjacent sequences of exon-intron borders were amplified by PCR using gene-specific primers. Primers were designed by means of the 'Primer3' program (Rozen and Skaletsky, 2000) . Purification of the PCR-amplified products was performed with a commercially available kit (Marligen Biosciences, Ijamsville, MD, USA). The purified PCR products were then sequenced with an ABI Prism310 Genetic Analyzer (Applera, Foster City, CA, USA) using a Big Dye Terminator v3.1 Cycle Sequencing Kit. BioEdit sequence alignment tools (editor version 6.0.7, Ibis Biosciences, Carlsbad, CA, USA) were used to detect pathogenic sequence variants in the gene GALNS.
In silico structural and functional analysis
Bioinformatics analyses were carried out to investigate the effects of mutations on protein structure and function. The 3D X-ray structure of human GALNS with the resolution 2.2 Å was retrieved from the protein databank (http:// www.rscb.org./pdb; code 4FDI), while the structure of N-acetylgalactosamine-6-sulfate (GalNAc-6S, CID 193456) (C6S, CID 24766) was retrieved from PubChem (RiveraColón et al., 2012) . All the water molecules were removed from the structure and hydrogen atoms were added. This structure was then energy minimized with amber 99 force field in the MOE software packages (http://www. chempcomp.com). Structures of the mutants were developed by changing the selected residue into the desired residue followed by refinement of the structures by subjecting to a similar energy minimization protocol that was used for the wild-type structure. Wild-type GALNS protein and its mutants were superimposed and their root mean square deviation (RMSD) and potential energy were calculated. The molecular docking study was carried out against 6S-GalNAc as a substrate to predict the docking score and binding pose of the ligand in the active site. Docking scores were calculated on the basis of numbers of rotatable bonds immobilized in ligand protein complex formation. A higher docking score revealed a decrease in binding affinity of the protein and vice versa. The predicted 3D structure of the protein and docking pose were visualized by PyMOL (http://pymol.org/, The PyMOL Molecular Graphics System, version 1.3; Schrödinger, LLC).
Results
Clinical features
Affected members in eight families (A-H) shared phenotypic similarities with some differences (Table 1) . Clinical features of affected individuals included marked skeletal deformities such as disproportionate short stature, petite neck and trunk, pectus carinatum i.e. pigeon chest, broad mouth, dental anomalies, valgus deformities of the knees, and abnormal flexibility of joints. Kyphoscoliosis i.e. combination of outward curvature (kyphosis) and lateral curvature (scoliosis) of the spine, abnormal faces, curved leg bones, and platyspondyly characterized by flattened vertebral bodies throughout the axial skeleton were observed in affected individuals (Figure 2 ). Affected members in families A and B showed noteworthy short stature with 4-5 SDS below normal with no associated intellectual complications. Affected members of C and D showed severe phenotypes of the syndrome. Two affected members in family D died at the age of 13-15 years. Patients in families E, F, and G were most severely affected; they were unable to walk and had insightful intellectual disability. A short life span was observed in affected individuals of family H and four individuals died at the age of 18-23.
Linkage analysis and mutation screening
Linkage in the families was tested using microsatellite markers flanking the GALNS gene on chromosome 16q24.3. Except for family H, linkage in all the families was established to GALNS. All 14 exons of the GASLNS, including exon intron boundaries, were sequenced in affected and unaffected members of the seven families. Sequence analysis detected a homozygous missense mutation (c.1259C > G; p.Pro420Arg) in exon 12 of GALNS in affected members of families A and B (Figures  3a-3c) . In family C, a missense mutation (c.1156C > T, p.Arg386Cys) was found in exon 11 (Figures 3d-3f ) while affected members in family D showed another missense mutation (c.647T > C; p.Phe216Ser) in exon 7 of the gene (Figure 3g-3i) . In three families (E, F, G) there was a frameshift mutation, involving insertion of adenine between nucleotide number 360 and 361 (c.360-361InsA; p.Glu121Argfs*37) (Figure 3j-3l ) that resulted in changing the open reading frame of the protein after amino acid number 120 with a premature stop codon 37 amino acids ahead the frameshift.
A DNA sample of an affected member (V-5) from family H, which failed to show linkage, was subjected to targeted next generation sequencing using TruSight One Sequencing Panel. Taking into consideration the phenotypes observed in the family, a panel of genes was piled up encompassing 18 genes, which have been reported in literature to be associated with mucopolysaccharidosis and related syndromes (Table 2) . Downstream analysis revealed two heterozygous missense mutations (c.114T > G; c.871G > T: p.Met38Arg; p.Ala291Ser) in GALNS whereas no pathogenic sequence variant was observed in the rest of the 17 genes. Sanger sequencing showed that affected individuals (V-3, V-5) were heterozygous for both mutations alleles [c.114T > G; c.871G > T] in exons 1 and 8, respectively. On the other hand, only one heterozygous variant (c.114T > G) was found in their mother and (c.871G > T) in their father (Figure 3m-3r) .
In silico structural and functional analysis
PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), an online tool, was used to analyze the impact of missense mutations on the structure and functions of the protein.
It was revealed that all five mutations-P.Pro420Arg, p.Arg386Cys, p.Phe216Ser, Ala291Ser, and Ala38Arg-were probably damaging with a pathogenicity score of 0.709, 1.00, 0.984, 0.999, and 0.984, respectively. The possible pathogenic impact of frameshift mutation (c.360-361InsA; p.Glu121Argfs*37) was checked using Mutation Taster (http://www.mutationtaster.org), which showed the mutation is disease causing with a maximum probability score of 1.00.
Effect of mutations on intermolecular interactions and protein's confirmation
The structure of the entire GALNS protein was developed and labeled with missense mutations (P.Pro420Arg, p.Arg386Cys, p.Phe216Ser, Ala291Ser, and Ala38Arg) according to their positions in the protein ( Figure 4A ). Using PyMOL software, the effect of mutations on intermolecular interactions was evaluated. In the case of p.Prro420Arg, a nonpolar amino acid (Proline420) is replaced by a larger and more positively charged arginine. As a result, a guanidium group is introduced in the loop region to develop an intermolecular hydrogen bond with side chain of Ala291 (Figures 4a and 4b) , thereby distorting the protein conformation. On the other hand, with substitution of Arginine386 by cysteine in the case of p.Arg386Cys, the intermolecular interaction between Arg386 with Ala104 and Thr406 is lost, affecting the protein folding (Figures 4c and 4d ). In the case of the third missense mutation (p.Phe216Ser), H-bonding among Phe216, Val134, Phe226, and Leu228 is demolished. The Ser216 developed new interactions with three residues (Leu34, Val138, Ile217), which altered the 3D structure of the protein (Figures 4e and 4f) . Similarly, substitution of methionine 38 by arginine (p.Met38Arg) resulted in loss of the intermolecular interaction with Trp230, Val232, and Phe285, distorting β sheet conformation (Figures 4g and  4h) . Replacement of alanine 291 by serine (p. Ala291Ser) resulted in generation of an additional interaction with Gly301 in addition to its interaction with Cys308 and Asn303 (Figures 4i and 4j) . 
Calculating potential energy
The stability of the protein was scrutinized by calculating the difference between potential energy of wild-type GALNS protein and its mutants ( (Figures 5a-5f ).
Discussion
Morquio A syndrome (MPS IVA; MIM #253000) is an autosomal recessive disorder caused by mutations in the GALNS gene (NM 000512.4) located on chromosome 16q24.3 Yasuda et al., 2013) . To date more than 200 mutations have been reported in GALNS (Morrone et al., 2014a (Morrone et al., , 2014b Stenson et al., 2014) and this heterogeneity in the mutation spectrum is responsible for clinical variability in Morquio A patients (Tomatsu et al., 2005) . Depending upon the nature and position of the mutation, the structure and function of the protein is altered to different extents, resulting in variable clinical outcomes (Gnad et al., 2013) . In the present study, eight Pakistani consanguineous families with Marqiuo A syndrome (MPS IV A) were evaluated at clinical and molecular levels. Linkage was established in seven families to the GALNS gene on chromosome 16q24.3. Sequence analysis of the gene revealed two previously reported missense mutations: p.Pro420Arg in families A and B (Morrone et al., 2014a) and p.Arg386Cys in family C (Tomatsu et al., 2004) . In addition, two novel mutations were identified: a missense mutation (p.Phe216Ser) in family D and a frameshift mutation (p.Glu121Argfs*37) in families E, F, and G.
TruSight One Sequencing Panel analysis in family H, which failed to show linkage, detected a compound heterozygous mutation in affected individuals. Sanger sequencing confirmed that affected members of the family carried two novel mutant alleles including p.Met38Arg Online prediction tools such as Polyphen2, SIFT, and Mutation Taster, indicated that missense mutations discovered in this study probably have damaging effects on the protein. Further in silico modeling of normal GALNS protein and its mutants revealed that, according to the nature and position of mutation, these substitutions altered the intermolecular interactions within the protein, hence distorting the normal structure to a variable extent. The missense mutation (p.Pro420Arg), detected in families A and B, disturbed surface residues in domain 2 of the GALNS protein, affecting intermolecular contacts for correct protein functioning (Rivera-Colón et al., 2012) . The second mutation (p.Arg386Cys), reported in family C, resulted in disruption of the hydrophobic core of the GALNS protein.
The third missense mutation (p.Phe216Ser), detected in family D, occurs in the N-terminal domain of GALNS, affecting the glycosylation site of the protein. Alteration in the glycosylation site of the GALNS protein may affect the normal folding and endosome/lysosome trafficking of the protein (Wujek et al., 2004; Pohl et al., 2009 ). Frameshift mutation (p.Glu121Argfs*37), identified in three families, resulted in protein truncation with a premature stop codon 37 amino acids after frameshift. Compound heterozygous missense mutations in family H (p.Met38Arg and Ala291Ser) occur near the primary active site residues (Asp39, Asp40, Asp288, and Asn289) (Rivera-Colón et al., 2012) , most likely affecting the conformation of the active site and its substrate binding ability.
The difference between potential energy of the wildtype and mutant protein is a measure of the effect of mutation on protein stability (Khan and Vihinen, 2010; Zhang et al., 2010 Zhang et al., , 2012 . Our results demonstrated that missense mutations (p.Pro420Arg, p.Ala291Ser, and p.Phe216Ser) resulted in the formation of additional intramolecular interactions. Eventually, an increase in PE was observed that may affect protein flexibility. In contrast, a decrease in PE occurred in the case of two missense mutations (p.Met38Arg and p.Arg386Cys) due to the loss of intramolecular interactions (Table 1) . Protein stability is a key feature of protein function, and a missense mutation may affect, besides the secondary structure, its stability, leading to misfolding (Dobson, 2003; Koukouritaki et al., 2007; Zhang et al., 2012) . In fact, protein folding involves fine-tuning of the linear unfolded polypeptide into the native 3D structure driven by the potential energy gradient (Ye et al., 2006; Dill et al., 2007) . Recent studies revealed that 80% of pathogenic missense mutations are amino acid substitutions that affect the stability of proteins by several kcal/mol (Wang and Moult, 2001 ). In addition, the missense mutation can also alter protein flexibility (Young et al., 2001; Karplus and Kuriyan, 2005; Zhang et al., 2010) . Generally, small energy values point toward a less stable protein and vice versa.
Using GalNAc-6S as a ligand, molecular docking analysis of normal and mutant GALNS protein revealed that normal protein had a strong binding affinity (lower docking score) than its mutant counterparts (high docking score). Inconsistencies in binding affinities of mutated proteins are a sign of geometrical constrains and/or energetic effects caused by missense mutations (Akhavan et al., 2005; Jones et al., 2007) .
In conclusion, eight consanguineous families with Morquio A syndrome were evaluated at clinical and molecular level. Genetic analysis revealed six mutations in the families including four novel (three missense and one frameshift) and two previously reported mutations.
In seven families the mutations occurred in homozygous state while in one family compound heterozygous mutations were identified causing severe phenotypes of variable degree. Further, in silico analysis revealed that these mutations alter the 3D structure, stability, and binding affinity of the protein. Phenotypic variability in the eight families was attributed to the deteriorations in GALNS caused by mutations. For instance, frameshift mutation resulted in the most severe phenotypes in three families, which included intellectual disability and facial Figure 4 . In silico structural modeling of GALNS mutations. The cartoon diagram of the entire GALNS protein comprehending N-terminal domain (D1) containing the active site in magenta and central domain (D2) with antiparallel β-strands in cyan, followed by followed by a C-terminal domain (D3) meander in yellow. The variants are featured in sphere models (A). Model structure of GALNS showing the effect of mutations on intermolecular interactions. Upper row indicates intermolecular interaction of the normal protein (a, c, e, g, i) , while the lower row presents intermolecular interactions in the case of Pro420Arg (b), Arg386Cys (d), Phe216Ser (f), Met38Arg (h), and Ala291Ser (j) mutants. The residues are symbolized in ball and stick models with a black dotted line displaying the interactions. dysmorphology. Moreover, these results suggest that in silico analysis is an effective approach to elucidate the impact of missense mutations on the structure and function of the protein and their ultimate influence on phenotypes.
